+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The synthesis of a peanut agglutinin-ricin A chain conjugate: potential as an in vitro purging agent for autologous bone marrow in multiple myeloma



The synthesis of a peanut agglutinin-ricin A chain conjugate: potential as an in vitro purging agent for autologous bone marrow in multiple myeloma



Experimental Hematology 23(13): 1347-1352



The lectin peanut agglutinin (PNA) and CD19 monoclonal antibody have been covalently linked to magnetic beads and utilized in an in vitro purging system for autologous bone marrow in multiple myeloma (MM). An alternative to mechanical purging involves the use of immunotoxins to provide specifically targeted cellular toxicity; however, no studies to date have examined the utility of a lectin-ricin A chain (RCA) combination as a purging agent in MM. Initially, we studied the internalization of PNA by target cells (Raji) using flow cytometry. The surface fluorescence intensity of PNA-treated Raji cells was reduced upon incubation at 37 degrees C, and subsequent studies with fixed cells detected the endocytosed PNA. Complete internalization occurred within 120 minutes, indicating the potential of PNA as a purging agent. We manufactured a novel PNA-RCA conjugate and demonstrated its strong and specific binding to PNA reactive cell targets. Subsequent experiments assessed the toxicity of the conjugate to Raji cells and normal bone marrow progenitor cells. 3H-leucine uptake assays showed that PNA-RCA was capable of reducing protein synthesis in Raji cells and that the toxic effects were specific. In addition, at concentrations of conjugate achieving greater than 99% selective cytotoxicity for Raji cells, adequate CFU-GM were preserved in normal marrow. These studies suggest that PNA-RCA may be of value as an in vitro purging agent for MM.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009630464

Download citation: RISBibTeXText

PMID: 7498362


Related references

A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody. Bone Marrow Transplantation 10(6): 485-489, 1992

Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma. Experimental Hematology 19(8): 833-837, 1991

Transferrin ricin a chain for ex vivo purging of small cell carcinoma cells from autologous bone marrow grafts. Clinical Research 38(1): 17A, 1990

Characterization of peanut agglutinin linked to ricin a chain potential therapeutic agent for human bladder cancer. Journal of Urology 143(4 SUPPL): 311A, 1990

Combined lectin/monoclonal antibody purging of bone marrow for use in conjunction with autologous bone marrow transplantation in the treatment of multiple myeloma. Methods in Molecular Medicine 9: 351-361, 1998

The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. Journal of Investigative Medicine 43(3): 269-274, 1995

Purging of autologous bone marrow by asta z in a murine model of multiple myeloma. Experimental Hematology 19(6): 567, 1991

Wheat germ agglutinin ricin a chain conjugate is a potent cytotoxin in vitro but is less active as a suicide transport agent in the central nervous system. Society for Neuroscience Abstracts 11(2): 1303, 1985

Complement dependent antibody mediated cytolysis of myeloma cells in vitro a model for autologous bone marrow purging. Proceedings of the American Association for Cancer Research Annual Meeting 27: 326, 1986

Lymphokine activated killer cells potential role as a purging agent for autologous bone marrow transplantation. Clinical Research 36(3): 410A, 1988

Wheat germ agglutinin ricin a chain conjugate a new semisynthetic suicide transport agent. Society For Neuroscience Abstracts: 352, 1984

Wheat germ agglutinin ricin a chain conjugate a semisynthetic suicide transport agent. Federation Proceedings 44(5): 1802, 1985

Multi-phase therapy of multiple myeloma using high-dose busulfan, melphalan and cyclophosphamide followed by autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging. Blood 82(10 SUPPL 1): 266A, 1993

Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation. Experimental Hematology 14(7): 626-635, 1986

Reconstitution Of Hematopoiesis After Bone Marrow Purging With Ricin A Chain Immunotoxin. Transplantation 41(3): 356-359, 1986